Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
LYEL Lyell Immunopharma
- 0.4621
- +0.0009+0.20%
Trading May 5 09:42 ET
136.48MMarket Cap-0.35P/E (TTM)
0.4650High0.4564Low3.13KVolume0.4564Open0.4612Pre Close1.44KTurnover0.00%Turnover RatioLossP/E (Static)295.34MShares2.875052wk High0.36P/B93.40MFloat Cap0.393152wk Low--Dividend TTM202.12MShs Float19.8400Historical High--Div YieldTTM1.87%Amplitude0.3931Historical Low0.4590Avg Price1Lot Size
About Lyell Immunopharma Company
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
Company Profile
SymbolLYEL
Company NameLyell Immunopharma
Listing DateJun 17, 2021
Issue Price17.00
Founded2018
CEODr. Lynn Seely,M.D.
MarketNASDAQ
Employees300
Fiscal Year Ends12-31
Address201 Haskins Way,Suite 101
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-695-0677
Websitehttp://www.lyell.com
Company Executives
- Name
- Position
- Salary
- Dr. Lynn Seely,M.D.
- Director, President and Chief Executive Officer
- 1.50M
- Stephen Hill
- Chief Operating Officer
- 1.34M
- Charles Newton
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Gary Lee, PhD
- Chief Scientific Officer
- --
- Dr. Richard D. Klausner, M.D.
- Chairman of the Board
- 288.07K
- Catherine J. Friedman
- Lead Independent Director
- 307.84K
- William J. Rieflin
- Independent Director
- 279.89K
- Robert Taylor Nelsen
- Independent Director
- 262.16K
- Dr. Sumant Ramachandra,M.D.,PhD
- Independent Director
- 177.27K
- Dr. Otis W. Brawley,M.D.
- Independent Director
- 265.34K
- Dr. Elizabeth G. Nabel, M.D.
- Independent Director
- 269.22K
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
